Describe the etiology.
Type I: anti-GBM glomerulonephritis: anti-glomerular basement membrane antibody disease (Goodpasture syndrome)
Type II: immune complex-mediated glomerulonephritis
IgA nephropathy
Membranoproliferative nephropathy
IgA vasculitis
Lupus nephritis
Poststreptococcal glomerulonephritis (PSGN)
Type III: glomerulonephritis associated with vasculitis (pauci-immune GN, ANCA-associated)
Granulomatosis with polyangiitis
Microscopic polyangiitis
Eosinophilic granulomatosis with polyangiitis
Describe the pathophysiology.
Breaks in the glomerular capillary wall and dysfunction of the glomerular basement membrane (GBM) → leakage of plasma proteins (e.g., coagulation factors) and passage of inflammatory cells (macrophages, T cells) into Bowman space
Release of inflammatory cytokines → damage to the membrane of Bowman space and passage of cells from the interstitium into Bowman space
This causes the formation of fibrin clots and proliferation of cells (e.g., macrophages, fibroblasts, neutrophils, epithelial cells) → crescent moon formation → compression of the glomerulus → renal dysfunction
List clinical features.
Nephritic syndrome
Decrease in urine output within days to weeks → possibly anuria
Fatigue
Pulmonary symptoms (e.g., hemoptysis) may occur (see “Differential diagnosis of pulmonary-renal syndromes”).
Zuletzt geändertvor 2 Jahren